These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4807231)

  • 1. [Vascular fragility of the endometrium under estrogen-progestin treatment. Treatment by disodium flavodate].
    Sarfati R; Brux J
    J Gynecol Obstet Biol Reprod (Paris); 1973; 2(1):87-94. PubMed ID: 4807231
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombelastographic evaluation of blood coagulation during treatment with hormonal inhibitors of ovulation].
    Carlon G; Rampinelli L; Guidi P; Caburlotto L
    Riv Patol Clin Sper; 1966; 7(2):239-47. PubMed ID: 5960683
    [No Abstract]   [Full Text] [Related]  

  • 3. [Iatrogenic endometrial damage. Case report].
    Martínez JT; Alezard L; Solarte C
    Rev Obstet Ginecol Venez; 1970; 30(3):425-34. PubMed ID: 5513342
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical use of progestins in the menopausal patient: dosage and duration.
    Gambrell RD
    J Reprod Med; 1982 Aug; 27(8 Suppl):531-8. PubMed ID: 7131446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic steroid overloadings and contraception. Importance of conjunctive changes in the corporeal human uterine mucosa].
    Moricard R
    Bull Acad Natl Med; 1970 Jun; 154(23):588-99. PubMed ID: 4922868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic changes in the uterus associated with steroid contraceptives and intrauterine contraceptive devices.
    Ober WB
    Acta Cytol; 1970 Mar; 14(3):156. PubMed ID: 5265919
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of subdermal implants of estradiol and testosterone on the endometrium of postmenopausal women.
    Filho AM; Barbosa IC; Maia H; Genes CC; Coutinho EM
    Gynecol Endocrinol; 2007 Sep; 23(9):511-7. PubMed ID: 17943546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
    Speroff L
    Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestin replacement in the menopause: effects on the endometrium and serum lipids.
    Williams DB; Moley KH
    Curr Opin Obstet Gynecol; 1994 Jun; 6(3):284-92. PubMed ID: 8038417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regeneration of the endometrium after cessation of combined estrogen-progestin treatment].
    de Brux J; Tiburce P; Borghetti-Ancla M
    Gynecologie; 1973; 24(2):163-8. PubMed ID: 4802797
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vascular and gynecological consequences of estroprogestatives].
    Chabrier J; Choukroun J
    Phlebologie; 1972; 25(3):251-4. PubMed ID: 4662049
    [No Abstract]   [Full Text] [Related]  

  • 12. Progestins and the endometrium in patients receiving tamoxifen.
    Bertelli G; Venturini M; Bergaglio M; Gustavino C; Rosso R; Valenzano M
    Br J Cancer; 1999 Jun; 80(7):1114. PubMed ID: 10362126
    [No Abstract]   [Full Text] [Related]  

  • 13. Estrogen-progestin increases breast cancer risk.
    Stephens MB
    J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
    [No Abstract]   [Full Text] [Related]  

  • 14. Looking for the pony in the HERS data. Heart and Estrogen/progestin Replacement Study.
    Barrett-Connor E
    Circulation; 2002 Feb; 105(8):902-3. PubMed ID: 11864914
    [No Abstract]   [Full Text] [Related]  

  • 15. Responsiveness of endothelium in spiral arterioles of endometrium.
    Blaustein A; Shenker L
    Obstet Gynecol; 1970 Jan; 35(1):12-20. PubMed ID: 5409826
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of uterine bleeding in postmenopausal patients receiving estrogen alone or with a progestin.
    Flowers CE; Wilborn WH; Hyde BM
    Obstet Gynecol; 1983 Feb; 61(2):135-43. PubMed ID: 6296742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of estrogen/progestogen receptors in the endometrium.
    Casper RF
    Int J Fertil Menopausal Stud; 1996; 41(1):16-21. PubMed ID: 8673152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk and lack of overall benefit.
    South Med J; 2002 Aug; 95(8):795-7. PubMed ID: 12190211
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study.
    Schilling LH
    Contraception; 2009 Mar; 79(3):241; author reply 241-2. PubMed ID: 19185682
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral contraception with estrogen and progestin combinations.
    Board JA
    Curr Ther Res Clin Exp; 1971 Jan; 13(1):1-5. PubMed ID: 4992561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.